Demand spurs Investment in Production Capacity

In response to the current high demand for viral transport media, which has been intensified by the COVID-19 pandemic, Teknova has constructed dedicated new clean rooms, designed from scratch to meet the ISO 13485 and GMP standards required for production of its saline, VTM and ATM products.  The company also invested in advanced, high-throughput automated lines, significantly streamlining the media production process. Vice President of Engineering, Jose Olague, said: “Automating the manufacturing process enabled us to rapidly scale up production from 300,000 to over 1 million tubes per week, and control contamination risks even more tightly. The larger production volumes also mean we can offer an extremely competitive price on our transport media, ensuring value for customers and greater access to these important products.”

“At Teknova, we have an extremely flexible chain of raw material supply, with multiple suppliers for each formulation component that aligns perfectly with our automation capabilities and adaptability to accommodate differences in final packaging configurations. Our wealth of QC data accumulated over many years’ experience and expertise in reagent manufacturing also allow us to rapidly switch supplier if necessary—an important advantage to secure continuous supply to customers, given the uncertainty caused by the COVID-19 pandemic.”